NCT05945524View on ClinicalTrials.gov

Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 28, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

May 31, 2026

Conditions
Multiple Myeloma
Interventions
OTHER

Bone marrow sampling

Bone marrow sampling collected at 12 weeks after initiation treatment (day 1 cycle 4)

Trial Locations (18)

14033

RECRUITING

CHU de Caen, Caen

21000

RECRUITING

Polyclinique du Parc Drevon, Dijon

31059

RECRUITING

CHU de Toulouse, Toulouse

33600

RECRUITING

CHU de Bordeaux, Pessac

34295

RECRUITING

CHU de Montpellier, Montpellier

35033

RECRUITING

CHU de Rennes, Rennes

37044

RECRUITING

CHU de Tours, Tours

42271

RECRUITING

CH Saint-Etienne, Saint-Priest-en-Jarez

54500

RECRUITING

CHRU Nancy, Vandœuvre-lès-Nancy

59037

RECRUITING

CHU de Lille, Lille

69373

RECRUITING

Centre Léon Bérard, Lyon

69495

RECRUITING

CHU de Lyon, Pierre-Bénite

74370

RECRUITING

CH Annecy Genevois, Epagny Metz- Tessy

75010

RECRUITING

Hôpital Saint-Louis, Paris

75012

RECRUITING

Hôpital Saint-Antoine, Paris

75015

RECRUITING

Hôpital Necker, Paris

80054

RECRUITING

CHU d'Amiens, Amiens

86021

RECRUITING

CHU de Poitiers, Poitiers

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER